Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

A Novel Interruption Management Intervention for New Graduate Nurses During Medication Administration

14 maj 2026 uppdaterad av: Cidalia Vital, Baystate Medical Center

A Novel Interruption Management Intervention for New Graduate Nurses During Medication Administration: A Pilot Randomized Trial

The objective of this study was to evaluate the effect of education in the Stay S.A.F.E. interruption management strategy on nurses' responses to interruptions during simulated medication administration. Primary outcomes included 1) response to the interrupter, including adherence to Stay S.A.F.E. behaviors, and 2) time away from the primary task. Secondary outcomes included 1) medication administration errors and 2) perceived workload as measured by the NASA Task Load Index.

Studieöversikt

Detaljerad beskrivning

This pilot study was a randomized controlled trial that evaluated the impact of the Stay S.A.F.E training on new graduate nurses.

Studietyp

Interventionell

Inskrivning (Faktisk)

56

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Massachusetts
      • Springfield, Massachusetts, Förenta staterna, 01199
        • Baystate Medical Center

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Barn
  • Vuxen
  • Äldre vuxen

Tar emot friska volontärer

Ja

Beskrivning

Inclusion Criteria:

  • A convenience sample of new graduate nurses within the first year of practice as a nurse.

Exclusion Criteria:

  • nurses with >1 year of practice

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Övrig
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Enda

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Stay S.A.F.E. Interruption Management Education

The Stay S.A.F.E. strategy is a structured, behavioral approach designed to support task focus and safe task resumption during interruptions. It consists of the following steps:

Stay physically in the current location and remain engaged in the primary task; when possible, physically hold task-related items.

Say aloud what you are doing at the moment of interruption, being as specific as possible while maintaining patient privacy.

Acknowledge the person interrupting you without looking away from the primary task.

Fixate visually and cognitively on the current place in the task for one to two seconds and identify a natural stopping point.

Estimate the time needed to complete or pause the task before attending to the interrupter, providing a realistic timeframe.

11 slide narrated PowerPoint presentation focused on medication safety practices.
Sham Comparator: Medication Safety Education
11 slide narrated PowerPoint presentation focused on medication safety practices.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Response to Interrupter Using the Stay S.A.F.E. Strategy
Tidsram: During simulation (immediate assessment at interruption; within a 30 minute session)
The primary outcome is the participant's response to a clinical interruption, assessed using an eye tracking device (ETD). Study personnel recorded interruption management behaviors, Stay S.A.F.E., using a structured data collection tool and whether the participant immediately accepted the interruption ("took report").
During simulation (immediate assessment at interruption; within a 30 minute session)
Time away from primary task
Tidsram: During simulated interruption event (from onset of interruption to return to primary task; within a 30-minute session)
Time away from the primary medication-administration task is measured using eye tracking device (ETD) recordings. Two trained study team members review recorded sessions to determine the duration between the onset of the interruption and the participant's return to the primary task, defined as the point at which the participant's ETD crosshairs re-engage with the medication-administration activity. Time is calculated using timestamp data captured within the ETD recordings.
During simulated interruption event (from onset of interruption to return to primary task; within a 30-minute session)

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
medication administration errors
Tidsram: During simulation (real-time assessment with post-simulation validation; up to 30 minutes).

Medication administration errors are assessed during the simulation using a structured observational checklist. Evaluated components include patient identification (e.g., armband scanning and electronic medical record verification), medication identification, dosage, route, and timing.

Each task component is documented as:

Yes (correct task completion) No (incorrect task completion) Corrected (initially incorrect but subsequently corrected by the participant)

Data are initially recorded on a standardized paper checklist during the simulation. To ensure accuracy and reliability, two study team members perform an independent review of eye tracking device (ETD) recordings to validate observed performance and recorded outcomes.

Outcome data may be summarized as proportions of correctly completed tasks, error rates, and frequency of corrected actions.

During simulation (real-time assessment with post-simulation validation; up to 30 minutes).
Perceived Workload (NASA Task Load Index)
Tidsram: Immediately following the simulation (within a 30-minute session).

Perceived workload is assessed using the NASA Task Load Index (NASA-TLX), a validated self-report instrument developed by the NASA Ames Research Center. Participants complete the NASA-TLX electronically on an iPad immediately following the simulation The NASA-TLX consists of six subscales: mental demand, physical demand, temporal demand, performance, effort, and frustration. Each subscale is rated on a 20-point scale, with higher scores indicating greater perceived workload. Both overall workload scores and individual subscale scores are calculated and analyzed to characterize participant workload during the simulation.

The NASA-TLX has demonstrated reliability and validity across simulation, laboratory, and applied clinical settings.

Immediately following the simulation (within a 30-minute session).

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

13 maj 2024

Primärt slutförande (Faktisk)

25 september 2024

Avslutad studie (Faktisk)

25 september 2024

Studieregistreringsdatum

Först inskickad

11 maj 2026

Först inskickad som uppfyllde QC-kriterierna

14 maj 2026

Första postat (Faktisk)

20 maj 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

20 maj 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

14 maj 2026

Senast verifierad

1 maj 2026

Mer information

Termer relaterade till denna studie

Andra studie-ID-nummer

  • BaystateMC
  • no number provided (Annat bidrag/finansieringsnummer: Beta Zeta Chapter of Sigma Theta Tau)

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

IPD-planbeskrivning

Individual participant data will not be shared in accordance with institutional and IRB data sharing policies.

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera